Literature DB >> 28490488

Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.

Jennifer L Cannon1, Leslie Barclay2, Nikail R Collins3, Mary E Wikswo2, Christina J Castro4, Laura Cristal Magaña4, Nicole Gregoricus2, Rachel L Marine2, Preeti Chhabra5, Jan Vinjé6.   

Abstract

Noroviruses are the most frequent cause of epidemic acute gastroenteritis in the United States. Between September 2013 and August 2016, 2,715 genotyped norovirus outbreaks were submitted to CaliciNet. GII.4 Sydney viruses caused 58% of the outbreaks during these years. A GII.4 Sydney virus with a novel GII.P16 polymerase emerged in November 2015, causing 60% of all GII.4 outbreaks in the 2015-2016 season. Several genotypes detected were associated with more than one polymerase type, including GI.3, GII.2, GII.3, GII.4 Sydney, GII.13, and GII.17, four of which harbored GII.P16 polymerases. GII.P16 polymerase sequences associated with GII.2 and GII.4 Sydney viruses were nearly identical, suggesting common ancestry. Other common genotypes, each causing 5 to 17% of outbreaks in a season, included GI.3, GI.5, GII.2, GII.3, GII.6, GII.13, and GII.17 Kawasaki 308. Acquisition of alternative RNA polymerases by recombination is an important mechanism for norovirus evolution and a phenomenon that was shown to occur more frequently than previously recognized in the United States. Continued molecular surveillance of noroviruses, including typing of both polymerase and capsid genes, is important for monitoring emerging strains in our continued efforts to reduce the overall burden of norovirus disease.

Entities:  

Keywords:  genetic recombination; genotypic identification; noroviruses

Mesh:

Substances:

Year:  2017        PMID: 28490488      PMCID: PMC5483924          DOI: 10.1128/JCM.00455-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  74 in total

Review 1.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

2.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

3.  Emergence of a new recombinant Sydney 2012 norovirus variant in Denmark, 26 December 2012 to 22 March 2013.

Authors:  J Fonager; S Barzinci; T K Fischer
Journal:  Euro Surveill       Date:  2013-06-20

4.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

5.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

6.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

7.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

9.  Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008-2009.

Authors:  Preeti Chhabra; Daniel C Payne; Peter G Szilagyi; Kathryn M Edwards; Mary Allen Staat; S Hannah Shirley; Mary Wikswo; W Allan Nix; Xiaoyan Lu; Umesh D Parashar; Jan Vinjé
Journal:  J Infect Dis       Date:  2013-06-10       Impact factor: 5.226

10.  Complete Genome Sequence of a Recombinant GII.P16-GII.4 Norovirus Detected in Kawasaki City, Japan, in 2016.

Authors:  Yuki Matsushima; Tomomi Shimizu; Mariko Ishikawa; Ayako Komane; Nobuhiko Okabe; Akihide Ryo; Hirokazu Kimura; Kazuhiko Katayama; Hideaki Shimizu
Journal:  Genome Announc       Date:  2016-10-06
View more
  93 in total

Review 1.  Emergence of norovirus strains: A tale of two genes.

Authors:  Gabriel I Parra
Journal:  Virus Evol       Date:  2019-11-25

2.  Genetic Analysis of an Emerging GII.P2-GII.2 Norovirus Associated with a 2016 Outbreak of Acute Gastroenteritis in China.

Authors:  Yuanyun Ao; Xiaolu Xie; Xiaogen Dong; Miao Jin; Zhaojun Duan
Journal:  Virol Sin       Date:  2019-02-06       Impact factor: 4.327

3.  Genetic Diversity Among Genogroup II Noroviruses and Progressive Emergence of GII.17 in Wastewaters in Italy (2011-2016) Revealed by Next-Generation and Sanger Sequencing.

Authors:  E Suffredini; M Iaconelli; M Equestre; B Valdazo-González; A R Ciccaglione; C Marcantonio; S Della Libera; F Bignami; G La Rosa
Journal:  Food Environ Virol       Date:  2017-11-28       Impact factor: 2.778

4.  Homotypic and heterotypic protection and risk of re-infection following natural norovirus infection in a highly endemic setting.

Authors:  Preeti Chhabra; Saba Rouhani; Hannah Browne; Pablo Peñataro Yori; Mery Siguas Salas; Maribel Paredes Olortegui; Lawrence H Moulton; Margaret N Kosek; Jan Vinjé
Journal:  Clin Infect Dis       Date:  2020-01-09       Impact factor: 9.079

5.  Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Kari Debbink; Excel W Swann; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

6.  The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009-2016.

Authors:  Rachel M Burke; Minesh P Shah; Mary E Wikswo; Leslie Barclay; Anita Kambhampati; Zachary Marsh; Jennifer L Cannon; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

7.  Prevalence of Human Noroviruses in Commercial Food Establishment Bathrooms.

Authors:  Cortney M Leone; Muthu Dharmasena; Chaoyi Tang; Erin DiCAPRIO; Yuanmei Ma; Elbashir Araud; Hannah Bolinger; Kitwadee Rupprom; Thomas Yeargin; Jianrong Li; Donald Schaffner; Xiuping Jiang; Julia Sharp; Jan Vinjé; Angela Fraser
Journal:  J Food Prot       Date:  2018-05       Impact factor: 2.077

8.  Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran.

Authors:  Mahsa Farsi; Fatemeh Roodbari; Behrooz Nejati; Arash Arashkia; Somayeh Jalilvand; Alireza Nateghian; Aliakbar Rahbarimanesh; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Med Microbiol Immunol       Date:  2018-04-04       Impact factor: 3.402

9.  Prevalence and genetic diversity of viral gastroenteritis viruses in children younger than 5 years of age in Guatemala, 2014-2015.

Authors:  Marta Diez-Valcarce; Maria Renee Lopez; Beatriz Lopez; Oneida Morales; Manuel Sagastume; Loren Cadena; Susan Kaydos-Daniels; Claudia Jarquin; John P McCracken; Joe P Bryan; Jan Vinjé
Journal:  J Clin Virol       Date:  2019-03-09       Impact factor: 3.168

10.  Impact of long-term storage of clinical samples collected from 1996 to 2017 on RT-PCR detection of norovirus.

Authors:  Jennifer L Cannon; Marian Baker; Leslie Barclay; Jan Vinjé
Journal:  J Virol Methods       Date:  2019-02-06       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.